preprint
<title>Abstract</title> <bold>Background: </bold>People with epilepsy are more susceptible to psychiatric illnesses. The prevalence of depression is greater among people with epilepsy than among the general population. More severe co-morbid depression with epilepsy is linked to a poorer overall prognosis and a lower quality of life. <bold>Objective:</bold> This study assessed the prevalence of depression and associated factors among patients with epilepsy at public hospitals in Addis Ababa, Ethiopia. <bold>Methods: </bold>An institution based cross sectional study was conducted from July 1-30, 2023, among 591 epileptic patients in the follow-up units of Eka Kotebe General Hospital, St. Paul Hospital Millennium Medical College and Yekatit 12 Hospital Medical College. The study participants were selected via a systematic random sampling technique. A descriptive statistical method was used to generate frequencies and percentages. A Binary logistic regression model was used to assess the associations between independent variables and depression among epileptic patients. AORs were calculated and independent variables with p-value of ≤ 0.05 was considered significantly associated with depression among epileptic patients. The final model fitness was checked using the Hosmer- Lemshow goodness of fit test. <bold>Results:</bold> The prevalence of depression was 42.6%. Residence[AOR=0.26, 95% CI (0.17-0.39)], seizure frequency per month[AOR=2.24, 95% CI (1.23-4.10)], frequency of drug[AOR=1.98, 95% CI (1.19-3.28)] and social support[AOR=0.33, 95%CI (0.21-0.52) for moderate social support and AOR=0.46, 95% CI (0.28-0.77) for strong social support]were found to be significantly associated with depression. <bold>Conclusion:</bold> The prevalence of depression among patients with epilepsy at public hospitals in Addis Ababa was high. Healthcare professionals should emphasize epileptic patients with higher seizure frequency per month, a higher frequency of drug use and poor social support.Minster of health Should incorporate depression screening measures into existing epilepsy programs.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21203/rs.3.rs-5234453/v1
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.